Literature DB >> 26680371

Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.

Wen Sun1, Maria Parowatkin1, Werner Steffen1, Hans-Jürgen Butt1, Volker Mailänder1,2, Si Wu1.   

Abstract

The use of self-assembled nanostructures consisting of red-light-responsive Ru(II)-containing block copolymers (BCPs) for anticancer phototherapy is demonstrated. Three Ru-containing BCPs with different molecular weights are synthesized. Each BCP contains a hydrophilic poly(ethylene glycol) block and an Ru-containing block. In the Ru-containing block, more than half of the side chains are coordinated with [Ru(2,2':6',2''-terpyridine)(2,2'-biquinoline)](2+) , resulting in more than 40 wt% Ru complex in the BCPs. The Ru complex acts as both a red-light-cleavable moiety and a photoactivated prodrug. Depending on their molecular weights, the BCPs assemble into micelles, vesicles, and large compound micelles. All of the BCP assemblies are taken up by cancer cells. Red-light irradiation releases the Ru complex and generates singlet oxygen ((1) O2 ) in cancer cells. The released Ru complex and (1) O2 inhibit the growth of cancer cells. Among the three BCP assemblies, the BCP micelle exhibits the most efficient cellular uptake and best anticancer performance.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anticancer phototherapy; block copolymers; drug delivery; metallopolymers; self-assembly; stimuli-responsive

Mesh:

Substances:

Year:  2015        PMID: 26680371     DOI: 10.1002/adhm.201500827

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  8 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Ruthenium-Crosslinked Hydrogels with Rapid, Visible-Light Degradation.

Authors:  Teresa L Rapp; Christopher B Highley; Brian C Manor; Jason A Burdick; Ivan J Dmochowski
Journal:  Chemistry       Date:  2018-01-10       Impact factor: 5.236

3.  Water-Insoluble Photosensitizer Nanocolloids Stabilized by Supramolecular Interfacial Assembly towards Photodynamic Therapy.

Authors:  Yamei Liu; Kai Ma; Tifeng Jiao; Ruirui Xing; Guizhi Shen; Xuehai Yan
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

4.  Dynamic Supramolecular Ruthenium-Based Gels Responsive to Visible/NIR Light and Heat.

Authors:  Ian Teasdale; Sabrina Theis; Aitziber Iturmendi; Moritz Strobel; Sabine Hild; Jaroslaw Jacak; Philipp Mayrhofer; Uwe Monkowius
Journal:  Chemistry       Date:  2019-07-03       Impact factor: 5.236

5.  A Sequential Dual-Model Strategy Based on Photoactivatable Metallopolymer for On-Demand Release of Photosensitizers and Anticancer Drugs.

Authors:  Maomao He; Guangli He; Peiyuan Wang; Suhua Jiang; Ziyue Jiao; Dongmei Xi; Pengcheng Miao; Xuefei Leng; Zhiyong Wei; Yang Li; Yanjun Yang; Ran Wang; Jianjun Du; Jiangli Fan; Wen Sun; Xiaojun Peng
Journal:  Adv Sci (Weinh)       Date:  2021-10-18       Impact factor: 16.806

Review 6.  Polymeric Nanosystems Applied for Metal-Based Drugs and Photosensitizers Delivery: The State of the Art and Recent Advancements.

Authors:  Kele Cristina Ferreira Dantas; Jânia Dos Santos Rosário; Priscila Pereira Silva-Caldeira
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

7.  Reconfiguring surface functions using visible-light-controlled metal-ligand coordination.

Authors:  Chaoming Xie; Wen Sun; Hao Lu; Annika Kretzschmann; Jiahui Liu; Manfred Wagner; Hans-Jürgen Butt; Xu Deng; Si Wu
Journal:  Nat Commun       Date:  2018-09-21       Impact factor: 14.919

Review 8.  Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.

Authors:  Sarah I Bukhari; Syed Sarim Imam; Mohammad Zaki Ahmad; Parameswara Rao Vuddanda; Sultan Alshehri; Wael A Mahdi; Javed Ahmad
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.